Source:http://linkedlifedata.com/resource/pubmed/id/18480624
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2008-5-15
|
| pubmed:abstractText |
Expression of recently identified growth hormone-releasing peptide, ghrelin, and its receptor has been demonstrated in prostate cancer (PCA) cell lines. It was also shown that ghrelin has increased cell proliferation in vitro when added to PCA cell lines. The aim of this study was to evaluate the diagnostic value of serum ghrelin levels in detection of PCA.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1423-0399
|
| pubmed:author | |
| pubmed:copyrightInfo |
2008 S. Karger AG, Basel
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
80
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
245-8
|
| pubmed:meshHeading | |
| pubmed:year |
2008
|
| pubmed:articleTitle |
Diagnostic value of serum ghrelin levels in prostate cancer.
|
| pubmed:affiliation |
Department of Urology, Zonguldak Karaelmas University, School of Medicine, Zonguldak, Turkey. anmungan@yahoo.com
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|